Insights & Stories
Latest updates, interviews, and deep dives into the achievements of the world's most influential businesses across our award programmes.
Drug Shortages Turn Healthcare Supply Chains Into a Strategic Priority
Medicine shortages were once treated as an occasional procurement headache — a product that ran dry for a few weeks before normal service resumed....
Hospital-at-Home Becomes a Test of Logistics and Governance
Hospital-at-home has moved beyond the demonstration phase. What began as a way to free hospital beds during periods of pressure is now being designed...
Radiopharmaceuticals Become a Major Healthcare Investment Battleground
Radiopharmaceuticals are rapidly becoming one of the most competitive areas of healthcare investment as companies move to strengthen their positions...
Teladoc Expands AI Tools for Hospitals
Teladoc Health is expanding its use of artificial intelligence in hospitals with two new tools designed to help clinicians monitor patients and...
Oracle Health Data Breach Reportedly Affects Nearly 20 Million People
A cybersecurity breach involving Oracle’s healthcare business has reportedly exposed personal and medical information belonging to nearly 20 million...
WHO Advises Against Obesity Drugs for Children Under 10
The World Health Organization (WHO) has issued its first global guidelines specifically addressing childhood and adolescent obesity, recommending...
GE HealthCare’s $945 Million Sofie Acquisition Signals Growing Demand for Specialised Healthcare Facilities
GE HealthCare is making a major move into the expanding radiopharmaceutical market, agreeing to acquire Sofie Biosciences for $945 million in cash ....
FDA Tightens Focus on AI Medical Devices as Healthcare Technology Reshapes Facilities
Artificial intelligence is becoming increasingly embedded in healthcare, and U.S. regulators are responding with closer scrutiny of the medical...
Vaxcyte Takes Aim at Pfizer and Merck With New Pneumonia Vaccine
Vaxcyte has moved closer to challenging two of the biggest names in the pneumonia vaccine market after its experimental vaccine produced encouraging...
Lilly-Foghorn Cancer Drug Partnership Ends After Clinical Setback
Eli Lilly and biotechnology company Foghorn Therapeutics have ended a major cancer-drug collaboration after clinical data failed to show enough...